AR002690A1 - DERIVATIVE OF BENCIMIDAZOLE OR SALTS OF THE SAME, PHARMACEUTICAL COMPOSITION, IMMUNOSUPPRESSIVE AGENT AND ANTI-INFLAMMATORY AGENT THAT CONTAIN IT AND PROCEDURES TO PREPARE SUCH DERIVATIVE. - Google Patents
DERIVATIVE OF BENCIMIDAZOLE OR SALTS OF THE SAME, PHARMACEUTICAL COMPOSITION, IMMUNOSUPPRESSIVE AGENT AND ANTI-INFLAMMATORY AGENT THAT CONTAIN IT AND PROCEDURES TO PREPARE SUCH DERIVATIVE.Info
- Publication number
- AR002690A1 AR002690A1 ARP960103458A AR10345896A AR002690A1 AR 002690 A1 AR002690 A1 AR 002690A1 AR P960103458 A ARP960103458 A AR P960103458A AR 10345896 A AR10345896 A AR 10345896A AR 002690 A1 AR002690 A1 AR 002690A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- derivative
- salts
- bencimidazole
- procedures
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Measuring Volume Flow (AREA)
Abstract
La presente invención provee derivados bencimidazol novedosos o sales de los mismos representados por la fórmula general (I), en donde R1 es un átomo dehidrógeno o un átomo de halógeno; R2 es un grupo alquilo inferior fenilo; R4 es un grupohet erocíclico seleccionado del grupo que consiste de un grupoindolilo, grupo indolinilo, grupo 1H-indazolilo, grupo 2(1H)-quinolinonilo, grupo 3,4-dihidro-2(1H)-quinolinonilo y grupo 1,4-benzoxazinilo; A es un grupoalquileno inferior; n es 0 ó1. Lo s derivados de bencimidazol o sus sales de la presente invención son agentes efectivos para tratar diversas enfermedadesarterioscleróticas.The present invention provides novel benzimidazole derivatives or salts thereof represented by the general formula (I), wherein R1 is a hydrogen atom or a halogen atom; R2 is a phenyl lower alkyl group; R4 is an erocyclic heth group selected from the group consisting of an indolyl group, indolinyl group, 1H-indazolyl group, 2 (1H) -quinolinonyl group, 3,4-dihydro-2 (1H) -quinolinonyl group, and 1,4-benzoxazinyl group ; A is a lower alkylene group; n is 0 or 1. The benzimidazole derivatives or their salts of the present invention are effective agents for treating various arteriosclerotic diseases.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17180795 | 1995-07-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR002690A1 true AR002690A1 (en) | 1998-03-25 |
Family
ID=15930095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP960103458A AR002690A1 (en) | 1995-07-07 | 1996-07-05 | DERIVATIVE OF BENCIMIDAZOLE OR SALTS OF THE SAME, PHARMACEUTICAL COMPOSITION, IMMUNOSUPPRESSIVE AGENT AND ANTI-INFLAMMATORY AGENT THAT CONTAIN IT AND PROCEDURES TO PREPARE SUCH DERIVATIVE. |
Country Status (16)
Country | Link |
---|---|
US (1) | US5998437A (en) |
EP (1) | EP0779887B1 (en) |
KR (1) | KR100231639B1 (en) |
CN (1) | CN1074413C (en) |
AR (1) | AR002690A1 (en) |
AT (1) | ATE201407T1 (en) |
AU (1) | AU703073B2 (en) |
DE (1) | DE69612949T2 (en) |
DK (1) | DK0779887T3 (en) |
ES (1) | ES2159036T3 (en) |
GR (1) | GR3036420T3 (en) |
HK (1) | HK1003436A1 (en) |
MX (1) | MX9701685A (en) |
PT (1) | PT779887E (en) |
TW (1) | TW381092B (en) |
WO (1) | WO1997003070A1 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6410584B1 (en) | 1998-01-14 | 2002-06-25 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells with indole derivatives |
WO2000020033A1 (en) * | 1998-10-05 | 2000-04-13 | Eisai Co., Ltd. | Tablets immediately disintegrating in the oral cavity |
US6200771B1 (en) | 1998-10-15 | 2001-03-13 | Cell Pathways, Inc. | Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia |
US6133271A (en) * | 1998-11-19 | 2000-10-17 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives |
US6187779B1 (en) | 1998-11-20 | 2001-02-13 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives |
US6369092B1 (en) | 1998-11-23 | 2002-04-09 | Cell Pathways, Inc. | Method for treating neoplasia by exposure to substituted benzimidazole derivatives |
US6034099A (en) * | 1998-11-24 | 2000-03-07 | Cell Pathways, Inc. | Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones |
US6077842A (en) * | 1998-11-24 | 2000-06-20 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives |
US6486155B1 (en) | 1998-11-24 | 2002-11-26 | Cell Pathways Inc | Method of inhibiting neoplastic cells with isoquinoline derivatives |
US6020379A (en) * | 1999-02-19 | 2000-02-01 | Cell Pathways, Inc. | Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia |
IL150526A0 (en) * | 2000-02-09 | 2003-02-12 | Procter & Gamble | 2-phenylcarbamoyl-benzimidazoles |
WO2003018008A1 (en) * | 2000-02-25 | 2003-03-06 | Shionogi & Co., Ltd. | Apo ai expression accelerating agent |
US7276529B2 (en) | 2002-03-20 | 2007-10-02 | Celgene Corporation | Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
US7893101B2 (en) | 2002-03-20 | 2011-02-22 | Celgene Corporation | Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof |
US6962940B2 (en) | 2002-03-20 | 2005-11-08 | Celgene Corporation | (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
US7208516B2 (en) | 2002-03-20 | 2007-04-24 | Celgene Corporation | Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
US7087790B2 (en) * | 2003-08-29 | 2006-08-08 | Rutgers, The State University Of New Jersey | Benzotropolone derivatives and modulation of inflammatory response |
EP1742637A4 (en) * | 2004-04-23 | 2011-06-08 | Paratek Pharm Innc | Transcription factor modulating compounds and methods of use thereof |
GB0601951D0 (en) | 2006-01-31 | 2006-03-15 | Novartis Ag | Organic compounds |
US20090299067A1 (en) * | 2008-05-30 | 2009-12-03 | Pagoria Philip F | New synthesis of 2,6-diamino-3,5-dinitropyrazine-1-oxide from 2,6-diaminopyrazine-1-oxide |
EP2844247A4 (en) * | 2012-04-20 | 2015-11-25 | Anderson Gaweco | Ror modulators and their uses |
ES2749433T3 (en) | 2014-06-23 | 2020-03-20 | Celgene Corp | Apremilast for the treatment of liver disease or abnormal liver function |
EP3174868B1 (en) * | 2014-08-01 | 2021-08-25 | Nuevolution A/S | Compounds active towards bromodomains |
KR102501049B1 (en) | 2021-12-20 | 2023-02-20 | 김학용 | Environment-affinitive panel for abalone cultivating shelter, environment-affinitive shelter assembly thereof, and abalone cultivation equipment using the same |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59148051A (en) * | 1983-02-14 | 1984-08-24 | Fuji Photo Film Co Ltd | Photosensitive silver halide material |
JPS61167952A (en) * | 1985-01-21 | 1986-07-29 | Fuji Photo Film Co Ltd | Multi-layered silver halide color photosensitive material |
JPH0749405B2 (en) * | 1985-12-26 | 1995-05-31 | 三共株式会社 | Renin-inhibiting peptide analogue |
JPH0784462B2 (en) * | 1986-07-25 | 1995-09-13 | 日清製粉株式会社 | Benzimidazole derivative |
US4851423A (en) * | 1986-12-10 | 1989-07-25 | Schering Corporation | Pharmaceutically active compounds |
JPH0820699B2 (en) * | 1987-10-08 | 1996-03-04 | 富士写真フイルム株式会社 | Direct positive color photographic light-sensitive material |
US4994477A (en) * | 1988-03-24 | 1991-02-19 | Abbott Laboratories | Heterocyclic renin inhibitors |
JP2869561B2 (en) * | 1989-05-22 | 1999-03-10 | 大塚製薬株式会社 | Platelet adhesion inhibitor |
EP0407217A1 (en) * | 1989-07-07 | 1991-01-09 | Schering Corporation | Pharmaceutically active compounds |
US5098924A (en) * | 1989-09-15 | 1992-03-24 | E. R. Squibb & Sons, Inc. | Diol sulfonamide and sulfinyl renin inhibitors |
MX9200299A (en) * | 1991-02-07 | 1992-12-01 | Roussel Uclaf | NEW NITROGENATED BICYCLE DERIVATIVES, THEIR PROCEDURE FOR PREPARING THE NEW INTERMEDIATE COMPOUNDS OBTAINED THEIR APPLICATION AS MEDICINES AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. |
PT100905A (en) * | 1991-09-30 | 1994-02-28 | Eisai Co Ltd | BICYCLE HYGIENEOUS HETEROCYCLIC COMPOUNDS CONTAINING BENZENE, CYCLOHEXAN OR PYRIDINE AND PYRIMIDINE, PYRIDINE OR IMIDAZOLE SUBSTITUTES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
GB9121776D0 (en) * | 1991-10-14 | 1991-11-27 | Fujisawa Pharmaceutical Co | Benzimidazole derivatives and process for preparation thereof |
PH31122A (en) * | 1993-03-31 | 1998-02-23 | Eisai Co Ltd | Nitrogen-containing fused-heterocycle compounds. |
JPH07133224A (en) * | 1993-11-10 | 1995-05-23 | Kyowa Hakko Kogyo Co Ltd | Medicine for arteriosclerosis |
-
1996
- 1996-06-28 TW TW085107861A patent/TW381092B/en not_active IP Right Cessation
- 1996-07-03 AU AU63181/96A patent/AU703073B2/en not_active Ceased
- 1996-07-03 EP EP96922213A patent/EP0779887B1/en not_active Expired - Lifetime
- 1996-07-03 KR KR1019970701465A patent/KR100231639B1/en not_active IP Right Cessation
- 1996-07-03 CN CN96190717A patent/CN1074413C/en not_active Expired - Fee Related
- 1996-07-03 DE DE69612949T patent/DE69612949T2/en not_active Expired - Fee Related
- 1996-07-03 US US08/793,312 patent/US5998437A/en not_active Expired - Fee Related
- 1996-07-03 AT AT96922213T patent/ATE201407T1/en not_active IP Right Cessation
- 1996-07-03 WO PCT/JP1996/001841 patent/WO1997003070A1/en active IP Right Grant
- 1996-07-03 ES ES96922213T patent/ES2159036T3/en not_active Expired - Lifetime
- 1996-07-03 DK DK96922213T patent/DK0779887T3/en active
- 1996-07-03 PT PT96922213T patent/PT779887E/en unknown
- 1996-07-03 MX MX9701685A patent/MX9701685A/en not_active IP Right Cessation
- 1996-07-05 AR ARP960103458A patent/AR002690A1/en unknown
-
1998
- 1998-03-27 HK HK98102607A patent/HK1003436A1/en not_active IP Right Cessation
-
2001
- 2001-08-20 GR GR20010401271T patent/GR3036420T3/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1003436A1 (en) | 1998-10-30 |
CN1074413C (en) | 2001-11-07 |
ES2159036T3 (en) | 2001-09-16 |
AU703073B2 (en) | 1999-03-11 |
CN1158129A (en) | 1997-08-27 |
KR970705559A (en) | 1997-10-09 |
EP0779887B1 (en) | 2001-05-23 |
DK0779887T3 (en) | 2001-11-26 |
ATE201407T1 (en) | 2001-06-15 |
DE69612949D1 (en) | 2001-06-28 |
MX9701685A (en) | 1997-06-28 |
GR3036420T3 (en) | 2001-11-30 |
US5998437A (en) | 1999-12-07 |
EP0779887A1 (en) | 1997-06-25 |
WO1997003070A1 (en) | 1997-01-30 |
DE69612949T2 (en) | 2001-09-20 |
KR100231639B1 (en) | 1999-11-15 |
PT779887E (en) | 2001-08-30 |
AU6318196A (en) | 1997-02-10 |
TW381092B (en) | 2000-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR002690A1 (en) | DERIVATIVE OF BENCIMIDAZOLE OR SALTS OF THE SAME, PHARMACEUTICAL COMPOSITION, IMMUNOSUPPRESSIVE AGENT AND ANTI-INFLAMMATORY AGENT THAT CONTAIN IT AND PROCEDURES TO PREPARE SUCH DERIVATIVE. | |
ES2191048T3 (en) | OXAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOUNDS THAT CONTAIN THEM. | |
ES2053508T3 (en) | COMPOUNDS OF 3-PIRROLIDINYL-THIO-1-AZABICICLO (3.2.0) HEPT-2-ENO-2-CARBOXILICOS. | |
ES2142798T3 (en) | DERIVATIVES OF 3-AMIDO PIRAZOL, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
ES2188194T3 (en) | 1,8-NAFTIRIDIN-4 (1H) -ONON REPLACED AS INHIBITORS OF PHOSPHODESTERASE 4. | |
ATE242625T1 (en) | CHELATE PREPARATIONS CONTAINING OXIME COMPOUNDS | |
NO971538L (en) | Purine and guanine compounds as inhibitors of PNP | |
PE59399A1 (en) | HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND METHODS TO INHIBIT THE RELEASE OF PEPTIDE � - AMYLOID AND / OR ITS SYNTHESIS THROUGH THE USE OF SUCH COMPOUNDS | |
TR200000671T2 (en) | Aromatic C16-C20-substituted tetrahydro prostaglandins useful as FP agonists. | |
AR033594A1 (en) | A COMPOUND DERIVED FROM 3-AROILINDOL, ITS USE, PROCEDURES TO PREPARE IT, A PHARMACEUTICAL COMPOSITION CONTAINING IT, A MEDICINAL CONSTITUTED BY SUCH COMPOUND, AND INTERMEDIARY COMPOUNDS | |
PT89814A (en) | METHOD FOR PREPARING NEW STYLBEN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
ES2059335T3 (en) | DERIVATIVES OF PIRIDO (3,2,1-IJ) -1,3,4-BENZOXADIAZINA, PROCEDURE FOR ITS OBTAINING, CORRESPONDING PHARMACEUTICAL PREPARATIONS AND INTERMEDIATE PRODUCTS USABLE IN THE PROCEDURE. | |
PE107999A1 (en) | 3-AMIDINOANILINE DERIVATIVES, ACTIVATED BLOOD COAGULATION FACTOR X INHIBITORS AND INTERMEDIARIES THEREOF | |
TR200000670T2 (en) | Aromatic C16-C20-substituted tetrahydro prostaglandins useful as FP agonists. | |
KR890006590A (en) | 4-aminopyridine derivative | |
CO5040004A1 (en) | 2-4-DIAMINO-1,3,5-TRIAZINAS, ITS PREPARATION AND EMPLOYMENT AS HERBICIDES AND PHYTO-REGULATORS | |
FI803264L (en) | 2-HYDROXIALKYL-3,4,5-TRIHYDROXIPIPERIDINER FOERFARANDE FOER FRAMSTAELLNING AV DEM OCH ANVAENDNING AV DEM SOM LAEKEMEDEL | |
IT1196423B (en) | BENZOTIAZOLIN-COMPOUNDS | |
CO5580721A2 (en) | FUNGICIDE COMPOSITION BASED ON AT LEAST A PYRIDYLMETILBENZAMIDE DERIVATIVE AND AT LEAST A DITIOCARBAMATE DERIVATIVE | |
AR021542A1 (en) | A COMPOSITE OF SULFONAMIDE AND THE PHARMACEUTICAL COMPOSITIONS AND PREPARATIONS CONTAINING IT | |
SE9001269L (en) | 2-SUBSTITUTED N, N'-DITRIMETOXBENZOYL PIPERAZINES, AND A PREPARATION METHOD FOR THESE AND THERAPEUTIC COMPOSITIONS CONTAINING THEM | |
DE69702775D1 (en) | Quinolinone derivatives and antiallergic compositions containing them | |
ES2057415T3 (en) | BICYCLE DERIVATIVES. | |
ES2045514T3 (en) | USE OF CHROMAN DERIVATIVES FOR THE TREATMENT OF DEPRESSIVE STATES. | |
AR004680A1 (en) | DERIVATIVES OF THE ALQUENIL-BENZOILGUANIDINA, PROCEDURE TO PREPARE THEM AND PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |